Registry Study for Optimal Management of Liver Failure in the Chinese Population

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

January 6, 2023

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2028

Conditions
Liver Failure
Interventions
PROCEDURE

ALF

Acute onset, no history of underlying liver disease, liver failure characterized by degree Ⅱ or above hepatic encephalopathy developed within 2 weeks

PROCEDURE

SALF

The onset was acute, with no history of underlying liver disease, and clinical manifestations of liver failure appeared between 2 and 26 weeks

PROCEDURE

ACLF

On the basis of chronic liver disease, the clinical manifestations of acute liver decompensation and liver failure appear in a short period

Trial Locations (14)

710061

RECRUITING

First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

Unknown

RECRUITING

Ankang Central Hospital, Ankang

NOT_YET_RECRUITING

Xiangya Hospital of Central South University, Changsha

NOT_YET_RECRUITING

Hanzhong 3201 Hospital, Hanzhong

NOT_YET_RECRUITING

Qilu Hospital of Shandong University, Jinan

NOT_YET_RECRUITING

First Hospital of Lanzhou University, Lanzhou

NOT_YET_RECRUITING

Weinan Central Hospital, Weinan

NOT_YET_RECRUITING

Air Force Medical University Tangdu Hospital, Xi'an

NOT_YET_RECRUITING

Shaanxi provincial people's hospital, Xi'an

RECRUITING

The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an

NOT_YET_RECRUITING

Xi 'an International Medical Center Hospital, Xi'an

RECRUITING

Xianyang Central Hospital, Xianyang

NOT_YET_RECRUITING

The Affiliated Hospital of Yan'an University, Yanan

NOT_YET_RECRUITING

General Hospital of Ningxia Medical University, Yinchuan

All Listed Sponsors
lead

First Affiliated Hospital Xi'an Jiaotong University

OTHER